Your are not logged in. | login
MPN&MPNr-EuroNet



about MPN&MPNr-EuroNet


Chair

Dr. Sylvie HERMOUET

Laboratoire d'Hématologie
Institut de Biologie
CRCINA, Inserm U1232
Institut de Recherche en Santé 2 (IRS-2)
22 Boulevard Benoni Goullin
44200 Nantes
France


Logistic Organizer



Batumi
Conference & Event Agency


Sponsored by



AB ANALITICA






BIOMEDICA

BioRad

EPPENDORF Poland



LABSYSTEM




NOVARTIS




PROMEGA


QIAGEN



QIALAB




SARSTEDT

SYNGEN


Meeting Programme

Diagnostic of Sporadic and Hereditary
Myeloproliferative Diseases

WEDNESDAY April 25th, 2018

 
17:15 - 17:40 Registration
17:40 - 18:00 Welcome and Schedule
 
18:00 - 19:15 Diagnosis and significance of mutations in MPNs Chair: Aleksander B. Skotnicki (PL)
18:00 - 18:25 Mutations and their clinical relevance in myeloproliferative neoplasms Grzegorz Helbig (PL)
18:25 - 18:50 Diagnostic and prognostic significance of molecular testing in myelofibrosis Tomasz Sacha (PL)
18:50 - 19:15 Diagnostic algorithm for Philadelphia negative myeloproliferative neoplasms Joanna Góra-Tybor (PL)
 
19:15 - 19:45 Corporate Symposium Chair: François Girodon (FR)
19:15 - 19:30 Trusted solutions and innovations in MPN mutation analysis (QIAGEN) Véronique Laloux (FR)
19:30 - 19:45 Droplet DigitalTM PCR for the investigation of point mutations and fusion genes of the MPN portfolio of diseases (BioRad) Adam Corner (UK)
 
20:00 Welcome Dinner
 

THURSDAY April 26th, 2018

 
08:30 - 10:30 MPN mutations (I): NGS detection, validation, and quantification Chair: Julia Asp (SE)
08:30 - 09:00 Mutational analyses in the era of next generation sequencing Katerina Machova Polakova (CZ)
09:00 - 09:30 Diagnostic work up of MPNs using next generation sequencing Manja Meggendorfer (DE)
09:30 - 09:50 Characterization of NGS QC using quality metrics Naomi Porret (CH)
09:50 - 10:10 JAK2 V617F detection and quantification by ddPCR Elisabeth Oppliger (CH)
10:10 - 10:25 A comparison of qPCR and ddPCR in quantitative evaluation of JAK2 V617F allele burden in patient with Ph negative MPNs Dorota Link-Lenczowska (PL)
 
10:30 - 11:00 Coffee/tea break
 
11:00 - 12:45 MPN mutations (II): NGS detection, validation, and quantification Chair: Elisabeth Oppliger (CH)
11:00 - 11:30 Employing NGS to describe the genomic landscape of triple-negative MPNs Tomasz Stokłosa (PL)
11:30 - 12:00 Mutations in diagnostic samples of PV analyzed by the TruSight Myeloid Sequencing panel Julia Asp (SE)
12:00 - 12:30 JAK2/CALR screening of the Danish background population Lasse Kjaer (DK)
12:30 - 12:45 Clinical relevance of JAK2V617F mutational load in patients with MPN from Republic of Macedonia (Single-center experience) Marija Popova-Labachevska (MK)
 
12:45 - 13:30 Lunch
13:30 - 14:00 Free Time for Networking and Poster Session
 
14:00 - 16:30 Hereditary Erythrocytosis & Thrombocytosis Chair: Mary Frances McMullin (UK)
14:00 - 14:45 Differential diagnoses of Congenital Polycythemias/Erythrocytoses and their Erythroid and Non-erythroid Phenotypes Josef Prchal (CZ/USA)
14:45 - 15:15 A Gain-of-Function Mutation in EPO causes Familial Erythrocytosis Jakub Zmajkovic (CH)
15:15 - 15:40 Interest of Next generation sequencing for the detection of Hereditary Erythrocytosis-associated mutations François Girodon (FR)
15:40 - 16:10 A comprehensive Next Generation Sequencing Gene Panel focused on Idiopathic Erythrocytosis Mark Catherwood (UK)
16:10 - 16:20 Erythrocytosis as the first symptom of the complex hypermanganesemia syndrome due to mutations in SLC30A10 encoding a human manganese transporter Holger Cario (DE)
16:20 - 16:30 Germline JAK2 L611S mutation in a child with thrombocytosis François Girodon (FR)
 
16:30 - 17:00 Coffee/tea break
 
17:00 - 18:00 NGS and HE Business Sessions in small groups and Networking
 
20:00 Gala Dinner
 

FRIDAY April 27th, 2018

 
09:00 - 11:15 Inflammation and immune response in MPNs Chairs: Dorota Link-Lenczowska (PL) and Magdalena Zawada (PL)
09:00 - 09:30 Inflammatory cytokines in MPNs: Potential biomarkers and drivers of disease progression Nina Friesgaard Øbro (UK)
09:30 - 10:00 Impact of HSP27 in myelofibrosis as a new regulator of the JAK2/STAT5 signaling Aurélie de Thonel (FR)
10:00 - 10:30 The TLR4 and RAGE receptors conversely regulate pro-inflammatory S100A8/9 inhibition of proliferation-linked signaling in MPNs Vladan Cokic (RS)
10:30 - 11:00 Immune response to glycolipidic antigens in MPNs and other chronic hematological diseases Sylvie Hermouet (FR)
 
11:00 - 11:30 Coffee/tea break
 
11:30 - 12:30 General business session Chairs: Sylvie Hermouet (FR) and François Girodon (FR)
14th MPN&MPNr-EuroNet meeting in Belgrade (Spring 2019) Vladan Cokic (RS)
MPN&MPNr-EuroNet Budget 2017-2018 Sylvie Hermouet (FR)
MPN&MPNr-EuroNet in 2019 and beyond
 
12:30 - 13:30 Lunch
13:30 Meeting Adjourn - Good bye